Trials / Completed
CompletedNCT03765294
A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea
A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Idorsia Pharmaceuticals Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted to investigate the effects of ACT-541468 on nighttime respiratory function in patients with mild to moderate obstructive sleep apnea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACT-541468 | Film-coated tablet for oral use |
| DRUG | Placebo | Film-coated tablet for oral use |
Timeline
- Start date
- 2019-03-14
- Primary completion
- 2019-11-05
- Completion
- 2019-11-05
- First posted
- 2018-12-05
- Last updated
- 2019-12-19
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03765294. Inclusion in this directory is not an endorsement.